We Ask Analysts How Will Pharma and Medtech Companies Spend Billions in Repatriated OUS Profits? Artwork

OIS Podcast | Ophthalmology's leading Podcast

Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.

All Episodes

OIS Podcast | Ophthalmology's leading Podcast

We Ask Analysts How Will Pharma and Medtech Companies Spend Billions in Repatriated OUS Profits?

January 25, 2018 • OIS

Apple made headlines with a promise to spend repatriated dollars on R&D in the US. In this week’s podcast we talk with three Wall Street analysts to understand what we can expect to see from pharma and Medtech companies following the monster acquisitions of Juno, Kite et al. What ophthalmology companies might be acquisition targets? Will Medtech companies follow suit?